Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Alteplase 100 Mg Iv Inj[bchc] (CDM 80330209) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 13, 2026 , from http://ppman.hank.ai/transparency/procedure/80330209/by-state?code_type=CDM
“Alteplase 100 Mg Iv Inj[bchc] (CDM 80330209) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/80330209/by-state?code_type=CDM. Accessed
November 13, 2026 .
“Alteplase 100 Mg Iv Inj[bchc] (CDM 80330209) by State,” HANK Price Transparency ,
accessed November 13, 2026 ,
http://ppman.hank.ai/transparency/procedure/80330209/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
80330209 — Alteplase 100 Mg IV Inj[bchc]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$24,670
National median
$24,426 – $25,198
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 80330209 (CDM), with interquartile range
State Median p25 p75
NE $24,670 $24,426 $25,198